DrugPatentWatch Database Preview
Details for Patent: 10,076,514
Which drugs does patent 10,076,514 protect, and when does it expire?
Patent 10,076,514 protects GALAFOLD and is included in one NDA.
This patent has ten patent family members in six countries.
Summary for Patent: 10,076,514
| Title: | Methods of treating fabry disease in patients having the G9331A mutation in the GLA gene |
| Abstract: | Provided are methods of treating a patient diagnosed with Fabry disease and methods of enhancing .alpha.-galactosidase A in a patient diagnosed with or suspected of having Fabry disease. Certain methods comprise administering to a patient a therapeutically effective dose of a pharmacological chaperone for .alpha.-galactosidase A, wherein the patient has a splice site mutation in intron 4 of the nucleic acid sequence encoding .alpha.-galactosidase A. Also described are uses of pharmacological chaperones for the treatment of Fabry disease and compositions for use in the treatment of Fabry disease. |
| Inventor(s): | Benjamin; Elfrida (Millstone Township, NJ) |
| Assignee: | Amicus Therapeutics, Inc. (Cranbury, NJ) |
| Application Number: | 15/459,149 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 10,076,514
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Theraps Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | Start Trial | Start Trial | THE TREATMENT OF FABRY PATIENTS | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,076,514
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| China | 109069494 | Start Trial | |||
| European Patent Office | 3432882 | Start Trial | |||
| Japan | 2019510030 | Start Trial | |||
| South Korea | 102004114 | Start Trial | |||
| South Korea | 20180119691 | Start Trial | |||
| South Korea | 20190087673 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
